Pediatric Medications, Adult Medications (Respiratory Medications/Antibiotics), Digestive System Medications Manufacturer & Supplier

ABOUT US

Huluwa Pharmaceutical Group is a publicly listed company headquartered in Haikou, the capital of Hainan Province, China. As one of the top 20 industrial manufacturers in Hainan Province, Huluwa is committed to driving drug innovation and providing comprehensive health solutions. Huluwa specializes in the R&D, manufacturing, and commercialization of pharmaceutical products across multiple therapeutic areas, including pediatric medications, adult medications, gynecological medications, digestive system medications, and cardiovascular & cerebrovascular medications. The company is engaged in the export of pharmaceuticals and chemical raw materials, while also importing and distributing a diverse array of international drugs, foods for special medical purposes, and health products. We also license patented drugs for international partnerships and provide CMO / CDMO services to both domestic and international clients.

FOUR KEY ADVANTAGES

Advanced Production Bases

..................................................
6 intelligent & standardized production bases

LEARN MORE
Industry-Leading Enterprise

..................................................

Top 20 in Hainan
Top 10 in TCM development
Top 40 TCM enterprise in China

LEARN MORE
ESG Commitment

........................................................
Committed to the ESG principles
Chairman Liujingping honored with China’s top charity award

LEARN MORE
Pediatric Medicine Contribution Award

........................................................
“Outstanding Contribution Award for Tailor-Made Pediatric Medicines” from the WHO

LEARN MORE

PRODUCT CENTER

Huluwa currently hold 337 drug approvals, catering to various therapeutic areas such as pediatrics, adults, gynecology, gastrointestinal, cardiovascular & cerebrovascular, and respiratory systems.

Azithromycin for Injection

Strength：0.5 g
Functions and Indications：For the treatment of infections caused by susceptible organisms (See the package insert for details).

Bromhexine Hydrochloride for Injection

Strength：4mg
Functions and Indications：For patients with bronchitis, asthma, bronchiectasis or silicosis who have difficulty expectorating sticky phlegm.

Omeprazole Sodium for Injection

Strength：40mg
Functions and Indications：
Mainly indicated for:

① peptic ulcer hemorrhage, anastomotic ulcer hemorrhage;

② acute gastric mucosal lesion in concurrence with stress state, acute gastric mucosal damage caused by nonsteroidal anti-inflammatory drugs;

③ prevention of upper gastrointestinal hemorrhage in patients with stress state due to severe conditions (e.g., cerebral hemorrhage, serious trauma, etc.) or after a gastric operation;

④ as a substitution therapy for the following conditions: duodenal ulcer, gastric ulcer, reflux esophagitis and Zollinger-Ellison symptom where other oral therapy is not available.

Xiao Er Fei Re Ke Chuan Granules

Strength：4g
Functions and Indications：
Clearing heat and removing toxin; diffusing the lungs to stop cough; resolving phlegm to relieve panting. For pediatric patients with common cold, and/or bronchitis manifesting the symptom of phlegm and heat congesting in the lungs.

DOMESTIC BUSINESS

Huluwa specializes in the R&D, manufacturing, and commercialization of pharmaceutical products across multiple therapeutic areas, including pediatric medications, adult medications, gynecological medications, digestive system medications, and cardiovascular & cerebrovascular medications.

INTERNATIONAL BUSINESS

Huluwa is engaged in the export of pharmaceuticals and chemical raw materials, while also importing and distributing a diverse array of international drugs, foods for special medical purposes, and health products. We also license patented drugs for international partnerships and provide CMO / CDMO services to both domestic and international clients.

ORAL DISSOLVING FILM

An innovative dosage form that rapidly dissolves via the oral mucosa for drug absorption. Key advantages include:
Convenient administration, rapid onset of action, high patient compliance, strong stability. Additional features include customizable film parameters (e.g., thickness, shape, release speed) to meet personalized treatment needs; reduced waste during production and use, aligning with environmental principles.
NEBULIZED INHALATION FORMULATIONS

Nebulized inhalation formulations disperse drugs into fine mist or particles, directly targeting the affected area through the respiratory tract. Key advantages include:
Precise targeted action, rapid and efficient onset of action, convenient and flexible use, wide applicability, and synergistic multi-drug combinations (mixing multiple drugs for synergistic effects, flexible formula adjustments for personalized treatment, and enhanced efficacy).
TOPICAL FORMULATIONS (TRANSDERMAL ABSORPTION)

Topical formulations (transdermal absorption) act locally on the scalp through topical application, precisely targeting the lesions and ensuring safety. Core advantages include:High efficacy at the lesion site, minimized systemic impact, convenient and flexible use, and strong adaptability in dosage form.

ORAL DISSOLVING FILM

An innovative dosage form that rapidly dissolves via the oral mucosa for drug absorption. Key advantages include:
Convenient administration, rapid onset of action, high patient compliance, strong stability. Additional features include customizable film parameters (e.g., thickness, shape, release speed) to meet personalized treatment needs; reduced waste during production and use, aligning with environmental principles.

NEBULIZED INHALATION FORMULATIONS

Nebulized inhalation formulations disperse drugs into fine mist or particles, directly targeting the affected area through the respiratory tract. Key advantages include:
Precise targeted action, rapid and efficient onset of action, convenient and flexible use, wide applicability, and synergistic multi-drug combinations (mixing multiple drugs for synergistic effects, flexible formula adjustments for personalized treatment, and enhanced efficacy).

TOPICAL FORMULATIONS (TRANSDERMAL ABSORPTION)

Topical formulations (transdermal absorption) act locally on the scalp through topical application, precisely targeting the lesions and ensuring safety. Core advantages include:High efficacy at the lesion site, minimized systemic impact, convenient and flexible use, and strong adaptability in dosage form.

ORAL DISSOLVING FILM

NEBULIZED INHALATION FORMULATIONS

TOPICAL FORMULATIONS (TRANSDERMAL ABSORPTION)

NEWS AND EVENTS

9-Year Commitment - Volunteers from Huluwa Pharmaceutical Group Join Children from Haikou Social Welfare Home in Painting a Vision for the Free Trade Port

On March 8, Haikou Children's Welfare Institution resonated with laughter as Huluwa Pharmaceutical Group, in collaboration with Hainan Xuridongsheng Charity Foundation, launched the “Growing Together, Painting Future” public welfare campaign. This marks the 9th consecutive year that Huluwa Pharmaceu

08 March 2025

Huluwa Pharmaceutical Group Recognized as a “National Green Factory” for Pioneering Green Manufacturing

Huluwa Pharmaceutical Group was recognized as a “National Green Factory” for 2024, marking another significant milestone in its commitment to green, low-carbon, and sustainable development.Huluwa Pharmaceutical Group integrates green development principles throughout its entire production chain. The

22 December 2024

Huluwa Pharmaceutical Group Chairman Liu Jingping Wins China Charity Award

On September 5, the 12th China Charity Award ceremony, sponsored by the Ministry of Civil Affairs, was held at the Great Hall of the People in Beijing on China Charity Day. Liu Jingping, Chairman of Huluwa Pharmaceutical Group, was honored with the 12th China Charity Award for her sustained dedicati

05 September 2023

ABOUT US

FOUR KEY ADVANTAGES

PRODUCT CENTER

DOMESTIC BUSINESS

INTERNATIONAL BUSINESS

NEWS AND EVENTS

QUICK LINKS

PRODUCT